Advertisement for orthosearch.org.uk
Results 1 - 10 of 10
Results per page:
Bone & Joint 360
Vol. 10, Issue 5 | Pages 7 - 10
1 Oct 2021
Morris DLJ Cresswell T Espag M Tambe AA Clark DI Ollivere BJ


Bone & Joint 360
Vol. 10, Issue 1 | Pages 4 - 9
1 Feb 2021
White JJE Manktelow ARJ


Bone & Joint 360
Vol. 8, Issue 5 | Pages 4 - 10
1 Oct 2019
Tsoi K Samuel A Jeys LM Ashford RU Gregory JJ


Bone & Joint 360
Vol. 9, Issue 1 | Pages 4 - 9
1 Feb 2020
Logishetty K Muirhead-Allwood SK Cobb JP


Bone & Joint 360
Vol. 8, Issue 3 | Pages 3 - 7
1 Jun 2019
Patel NG Waterson HB Phillips JRA Toms AD


Bone & Joint 360
Vol. 7, Issue 6 | Pages 2 - 8
1 Dec 2018
Murray IR Safran MR LaPrade RF


Bone & Joint 360
Vol. 6, Issue 6 | Pages 2 - 10
1 Dec 2017
Luokkala T Watts AC


Bone & Joint 360
Vol. 5, Issue 2 | Pages 3 - 6
1 Apr 2016
Patel M Eastley N Ashford R

This paper aims to provide evidence-based guidance for the general orthopaedic surgeon faced with the presentation of a potential soft tissue sarcoma in an extremity.


Bone & Joint 360
Vol. 2, Issue 5 | Pages 8 - 12
1 Oct 2013
Phillips JRA

Not all questions can be answered by prospective randomised controlled trials. Registries were introduced as a way of collecting information on joint replacements at a population level. They have helped to identify failing implants and the data have also been used to monitor the performance of individual surgeons. This review aims to look at some of the less well known registries that are currently being used worldwide, including those kept on knee ligaments, ankle arthroplasty, fractures and trauma.


Bone & Joint 360
Vol. 2, Issue 6 | Pages 2 - 8
1 Dec 2013
Jones R Wood D

This article provides an overview of the role of genomics in sarcomas and describes how new methods of analysis and comparative screening have provided the potential to progress understanding and treatment of sarcoma. This article reviews genomic techniques, the evolution of the use of genomics in cancer, the current state of genomic analysis, and also provides an overview of the medical, social and economic implications of recent genomic advances.